推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 佰利聯(lián)1月26日晚公告稱(chēng)，擬以18.93元/股向5名特定投資者定增4000萬(wàn)股，募集資金7.57億元，其中5億元將用于償還銀行貸款，其余不超過(guò)2.57億元的部分用于補(bǔ)充營(yíng)運(yùn)資金。
5名特定投資者中，許剛為公司董事長(zhǎng)，此次擬認(rèn)購(gòu)2000萬(wàn)股；譚瑞清為公司副董事長(zhǎng)，擬認(rèn)購(gòu)1000萬(wàn)股；常以立為公司董事，擬認(rèn)購(gòu)400萬(wàn)股；楊民樂(lè)為公司董事、副總經(jīng)理，擬認(rèn)購(gòu)500萬(wàn)股；和奔流為公司總經(jīng)理，擬認(rèn)購(gòu)100萬(wàn)股。
公司表示，本次非公開(kāi)發(fā)行完成后，公司資本實(shí)力和抗風(fēng)險(xiǎn)能力將得到有效提升，公司各項(xiàng)業(yè)務(wù)的經(jīng)營(yíng)效率將得到相應(yīng)的提高，公司在國(guó)內(nèi)鈦白粉行業(yè)的領(lǐng)先優(yōu)勢(shì)將得到充分發(fā)揮，氯化法鈦白粉和歐洲市場(chǎng)兩個(gè)新增長(zhǎng)點(diǎn)的順利發(fā)展也能得到切實(shí)的流動(dòng)資金保障，提高了公司的長(zhǎng)期盈利能力和行業(yè)競(jìng)爭(zhēng)力。
